NEW YORK, May 9 - As a June deadline for commercializing its 10,000 gene human microarrays looms, Corning’s Microarray Technology division is finding out what Affymetrix already knows: It’s tougher than you think to make a highly reproducible high-density microarray.

“We are still working the bugs out of the process, and working through the internal validation,” said Thomas Hinman, division vice president and general manager of CMT Life Sciences. “It has taken us longer than we wanted to.”

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.